Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.196EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.448EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.1 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.525EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.577EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.639EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.138EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used